Sg3 Management, LLC Cytokinetics Inc Call Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$34.35 - $46.38 $2.49 Million - $3.36 Million	-72,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $1.34 Million - $2.59 Million	72,500 New	72,500 $2.59 Million
Q1 2021 May 17, 2021	SELL	$18.57 - $25.68 $278,550 - $385,200	-15,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $2.96 Million - $5.56 Million	-194,200 Reduced 92.83%	15,000 $312,000
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $4.31 Million - $6.06 Million	209,200 New	209,200 $4.53 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.43B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.